A world of possibilities
Navigating life sciences and medtech to the extraordinary—driven by creativity, curiosity, and the courage to build a fulfilling journey.
-
Method for inducing artificial ageing in a stem cell and uses of said cell
What This Patent Covers This patent application defines a biotechnological method to model and then reverse cellular aging using human induced pluripotent stem cells (iPSCs) — closely aligned with Clock.bio’s core research mission of decoding…
-
Genetically Modified Primary Cells for Allogeneic Cell Therapy
What This Patent Covers This patent application claims engineered primary cells — such as stem cells, islet cells, T cells, NK cells, and other therapeutic cell types — that have been genetically modified to evade immune rejection…
-
Heterocyclic GLP‑1 Agonists
What This Patent Covers U.S. Patent No. 11,926,643 covers novel heterocyclic compounds that act as GLP‑1 (glucagon‑like peptide‑1) receptor agonists, including specific molecular structures and compositions intended to engage the GLP‑1 receptor — an important therapeutic…
BioTech IP Review 